Announcement • Jun 09
Emblem Cannabis Corporation completed the acquisition of Ayurcann Inc. from Ayurcann Holdings Corp. (CNSX:AYUR) for CAD 5.5 million. Emblem Cannabis Corporation proposed to acquire Ayurcann Inc. from Ayurcann Holdings Corp. (CNSX:AYUR) for CAD 5 million on April 12, 2026. The purchase price for the Transaction will be payable in cash on closing with the support of facilities generally available to Emblem. Upon closing of the Transaction, Emblem will acquire a comprehensive processing and manufacturing platform, including The Fuego, Xplor, and Happy & Stoned brands, together with all associated intellectual property, trademarks, brand assets, Ayurcann’s cannabis formulation, manufacturing, and packaging operations based in Pickering, Ontario, including Ayurcann’s interests in operational equipment and inventory, and other strategic assets.
The transaction is subject to regulatory approval, all government licenses required to operate the Ayurcann business, court approval and the satisfaction of customary closing conditions. The closing is currently anticipated to take place no later than May 15, 2026. As of June 3, 2026, the closing of the transaction is currently anticipated to take place on or about June 5, 2026, and in any event no later than June 30, 2026.
Emblem Cannabis Corporation completed the acquisition of Ayurcann Inc. from Ayurcann Holdings Corp. (CNSX:AYUR) for CAD 5.5 million on June 8, 2026. Total consideration was CAD 5.5 million, consisting of (1) a release of all amounts outstanding under the DIP Facility (CAD 2.1 million) and (2) cash consideration of CAD 3.4 million, funded through a combination of cash on hand and the proceeds of the DIP Facility assignment, paid to Alvarez & Marsal Canada Inc.
Management expects the transaction to be immediately accretive to both revenue and EBITDA while enhancing RWB's scale, manufacturing capabilities, product breadth and national distribution footprint. In addition, the combination is expected to generate operational synergies across cultivation, procurement, manufacturing, logistics and administration, while supporting continued product innovation and new product development.
Gowling WLG (Canada) LLP acted as legal advisor for Emblem Cannabis Corporation and Red White & Bloom Brands Inc. Bennett Jones LLP acted as legal advisor for Ayurcann Inc. and Ayurcann Holdings Corp. Reported Earnings • Nov 30
First quarter 2026 earnings released: CA$0.006 loss per share (vs CA$0.002 loss in 1Q 2025) First quarter 2026 results: CA$0.006 loss per share (further deteriorated from CA$0.002 loss in 1Q 2025). Revenue: CA$8.48m (up 2.1% from 1Q 2025). Net loss: CA$1.10m (loss widened 210% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 29
Full year 2025 earnings released: CA$0.018 loss per share (vs CA$0.022 loss in FY 2024) Full year 2025 results: CA$0.018 loss per share (improved from CA$0.022 loss in FY 2024). Revenue: CA$31.1m (up 24% from FY 2024). Net loss: CA$3.49m (loss narrowed 12% from FY 2024). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. 
